Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer.
Jakesz R, Hausmaninger H, Haider K, Kubista E, Samonigg H, Gnant M, Manfreda D, Tschurtschenthaler G, Kolb R, Stierer M, Fridrik M, Mlineritsch B, Steindorfer P, Mittlböck M, Steger G. Jakesz R, et al. Among authors: manfreda d. J Clin Oncol. 1999 Jun;17(6):1701-9. doi: 10.1200/JCO.1999.17.6.1701. J Clin Oncol. 1999. PMID: 10561206 Clinical Trial.
Vindesine-epirubicin versus vindesine-mitoxantrone in metastatic breast cancer.
Hausmaninger H, Lehnert M, Steger G, Sevelda P, Michlmayr G, Hehenwarter W, Fridrik M, Samonigg H, Schiller L, Manfreda D, et al. Hausmaninger H, et al. Among authors: manfreda d. Onkologie. 1989 Oct;12(5):225-9. doi: 10.1159/000216651. Onkologie. 1989. PMID: 2685688 Clinical Trial.
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.
Gnant M, Fitzal F, Rinnerthaler G, Steger GG, Greil-Ressler S, Balic M, Heck D, Jakesz R, Thaler J, Egle D, Manfreda D, Bjelic-Radisic V, Wieder U, Singer CF, Melbinger-Zeinitzer E, Haslbauer F, Sevelda P, Trapl H, Wette V, Wimmer K, Gampenrieder SP, Bartsch R, Kacerovsky-Strobl S, Suppan C, Brunner C, Deutschmann C, Soelkner L, Fesl C, Greil R; Austrian Breast and Colorectal Cancer Study Group. Gnant M, et al. Among authors: manfreda d. N Engl J Med. 2021 Jul 29;385(5):395-405. doi: 10.1056/NEJMoa2104162. N Engl J Med. 2021. PMID: 34320285 Clinical Trial.
Steroid hormone receptors and prognosis in breast cancer.
Daxenbichler G, Forsthuber EP, Marth C, Kemmler G, Wiegele J, Margreiter R, Müller L, Hausmaninger H, Manfreda D, Dapunt O. Daxenbichler G, et al. Among authors: manfreda d. Breast Cancer Res Treat. 1988 Dec;12(3):267-73. doi: 10.1007/BF01811239. Breast Cancer Res Treat. 1988. PMID: 3228589
[Diagnosis and therapy of breast cancer].
Judmaier F, Manfreda D. Judmaier F, et al. Among authors: manfreda d. Wien Med Wochenschr. 1981 Dec 31;131(23-24):571-4. Wien Med Wochenschr. 1981. PMID: 7336750 German. No abstract available.
[Diagnosis and surgery of mammary carcinoma].
Judmaier F, Manfreda D. Judmaier F, et al. Among authors: manfreda d. Wien Med Wochenschr. 1977 Mar 30;127(6):185-8. Wien Med Wochenschr. 1977. PMID: 868032 German. No abstract available.
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.
Colleoni M, Luo W, Karlsson P, Chirgwin J, Aebi S, Jerusalem G, Neven P, Hitre E, Graas MP, Simoncini E, Kamby C, Thompson A, Loibl S, Gavilá J, Kuroi K, Marth C, Müller B, O'Reilly S, Di Lauro V, Gombos A, Ruhstaller T, Burstein H, Ribi K, Bernhard J, Viale G, Maibach R, Rabaglio-Poretti M, Gelber RD, Coates AS, Di Leo A, Regan MM, Goldhirsch A; SOLE Investigators. Colleoni M, et al. Lancet Oncol. 2018 Jan;19(1):127-138. doi: 10.1016/S1470-2045(17)30715-5. Epub 2017 Nov 17. Lancet Oncol. 2018. PMID: 29158011 Clinical Trial.
14 results